Toronto-based stem cell therapy firm attracts US$225M in funding — one of the largest ever for a biotech venture – Financial Post
Financial Post |
Toronto-based stem cell therapy firm attracts US$225M in funding — one of the largest ever for a biotech venture
Financial Post … Canada a go-to destination for the jobs of the future. Bains was in Toronto for the announcement of US$225 million in Series A funding for the Toronto-based medical stem cell company BlueRock Therapeutics, one of the largest ever for a biotech company. |
